Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Zwolak

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Biotechnology|October 29, 2025
Author Correction: Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Nature Biotechnology|October 7, 2025
Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Cell Host & Microbe|April 25, 2023
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infectionsPeter T Buckley, Rita Chan, Jeffrey Fernandez, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Iscience|March 10, 2025
JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-GNataša Obermajer, Adam Zwolak, Kelly van de Ven, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Biotechnology|October 29, 2025
Author Correction: Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Nature Biotechnology|October 7, 2025
Folding-mediated secretion of pure bispecific antibodiesCholpon Tilegenova, Tun Liu, Qian Zhao, et al.
Cell Host & Microbe|April 25, 2023
Multivalent human antibody-centyrin fusion protein to prevent and treat Staphylococcus aureus infectionsPeter T Buckley, Rita Chan, Jeffrey Fernandez, et al.
Mabs|April 19, 2023
"Stapling" scFv for multispecific biotherapeutics of superior propertiesLauren E Boucher, Elisabeth Geyer Prinslow, Michael Feldkamp, et al.
Iscience|March 10, 2025
JNJ-78306358, a first-in-class bispecific T cell engaging antibody targeting CD3 and HLA-GNataša Obermajer, Adam Zwolak, Kelly van de Ven, et al.
Pageof 3